Wednesday, July 8, 2026

pharma · Solid Tumors · Primary Dysmenorrhea

Topiloric/Uriadec

News and analysis for Topiloric/Uriadec on NovaPharmaNews — regulatory, clinical, and market coverage.

SOUTH SAN FRANCISCO, CA, JP HQ
2 Employees
PMDA registrant Type
Company details
Status
Public
HQ
SOUTH SAN FRANCISCO, CA, JP
Employees
2
Programs
12
Drugs
7
Patents
52
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Topiloric/Uriadec — regulatory, clinical, and market coverage.

News and analysis for Topiloric/Uriadec on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Topiloric/Uriadec yet.

Back to company overview →